Definium Therapeutics Inc. Common Shares vs Ingersoll Rand — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Ingersoll Rand trades at $78.16 (market cap $29.97B). The key difference: Ingersoll Rand is far larger — about 6.4× Definium Therapeutics Inc. Common Shares's market cap, and Ingersoll Rand pays a 0.1% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Ingersoll Rand for 7 Days on average.
| DFTX | IR | |
|---|---|---|
Market Cap | $4.71B | $29.97B |
Volume | 1,966,636 | 4,688,805 |
Sector | Health | Industrials |
52-Week High | $48.45 | $98.76 |
52-Week Low | $10.68 | $68.54 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $3.67B | $33.63B |
Dividend Yield | — | 0.1% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →